North America Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024

List of Tables

The North America Competent Cells Market would witness market growth of 7.3% CAGR during the forecast period (2024-2031).

The US market dominated the North America Competent Cells Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $898.8 million by 2031. The Canada market is experiencing a CAGR of 9.4% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 9.4% during (2024 - 2031).

These cells, particularly Escherichia coli (E. coli) and other bacterial strains have a wide range of applications across various fields within biotechnology, pharmaceuticals, agriculture, and research. These cells are essential for molecular cloning techniques, where they are used to introduce foreign DNA into bacterial cells. This process involves transforming these cells with recombinant DNA molecules, typically carried on plasmids or other vectors. Cloning allows researchers to replicate and study specific DNA sequences, gene functions, and regulatory elements.

These cells serve as hosts for gene expression studies, enabling the production of proteins encoded by cloned genes. Researchers can induce the expression of recombinant proteins in these cells to study protein structure, function, and interactions. This application is crucial for pharmaceutical research, engineering, and therapeutic protein production. These cells are crucial in constructing and screening genomics, cDNA, and protein libraries. These libraries contain cloned DNA fragments or expressed genes, which serve as valuable resources for identifying novel genes, biomarkers, drug targets, and therapeutic candidates.

As pharmaceutical companies in Canada intensify their research efforts, there will be a higher demand for these cells used in genetic engineering and drug development processes. According to Statistics Canada, in 2020, the R&D pharmaceutical sector contributed $15.9 billion to the Canadian economy in GVA, an increase of 5.8% from the $15.0 billion generated in 2019. Just under half of this ($7.9 billion) was attributable to the direct impacts of the sector, which rose 4.5% from the $7.6 billion generated in 2019. Furthermore, The Mexican government, through agencies like CONACYT (Consejo Nacional de Ciencia y Tecnologia), provides research grants and funding opportunities specifically targeted at biotechnology and life sciences. These funds support research projects that require these cells for applications such as genetic engineering, biopharmaceutical development, and agricultural biotechnology. Therefore, rising R&D in pharmaceutical industry and rising government initiative are propelling the growth of the market.

Based on Type, the market is segmented into Chemically Competent Cells, Electrocompetent Cells, and Ultracompetent Cells. Based on Application, the market is segmented into Cloning, Protein Expression, Mutagenesis, and Others. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
Merck KGaA
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Promega Corporation
New England Biolabs, Inc.
Qiagen N.V
F. Hoffmann-La Roche Ltd.
Takara Bio Inc. (Takara Holdings Inc.)
Lonza Group Ltd. (Capsugel)

North America Competent Cells Market Report Segmentation

By Type

Chemically Competent Cells
Electrocompetent Cells
Ultracompetent Cells

By Application

Cloning
Protein Expression
Mutagenesis
Others

By End-Use

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Competent Cells Market, by Type
- 1.4.2 North America Competent Cells Market, by Application
- 1.4.3 North America Competent Cells Market, by End-Use
- 1.4.4 North America Competent Cells Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Competent Cells Market

Chapter 5. North America Competent Cells Market by Type

5.1 North America Chemically Competent Cells Market by Country
5.2 North America Electrocompetent Cells Market by Country
5.3 North America Ultracompetent Cells Market by Country

Chapter 6. North America Competent Cells Market by Application

6.1 North America Cloning Market by Country
6.2 North America Protein Expression Market by Country
6.3 North America Mutagenesis Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Competent Cells Market by End-Use

7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
7.2 North America Academic & Research Institutes Market by Country
7.3 North America Others Market by Country

Chapter 8. North America Competent Cells Market by Country

8.1 US Competent Cells Market
- 8.1.1 US Competent Cells Market by Type
- 8.1.2 US Competent Cells Market by Application
- 8.1.3 US Competent Cells Market by End-Use
8.2 Canada Competent Cells Market
- 8.2.1 Canada Competent Cells Market by Type
- 8.2.2 Canada Competent Cells Market by Application
- 8.2.3 Canada Competent Cells Market by End-Use
8.3 Mexico Competent Cells Market
- 8.3.1 Mexico Competent Cells Market by Type
- 8.3.2 Mexico Competent Cells Market by Application
- 8.3.3 Mexico Competent Cells Market by End-Use
8.4 Rest of North America Competent Cells Market
- 8.4.1 Rest of North America Competent Cells Market by Type
- 8.4.2 Rest of North America Competent Cells Market by Application
- 8.4.3 Rest of North America Competent Cells Market by End-Use

Chapter 9. Company Profiles

9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Product Launches and Product Expansions:
  - 9.1.5.3 Geographical Expansions:
- 9.1.6 SWOT Analysis
9.2 Merck KGaA
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Trail and Approvals:
- 9.3.6 SWOT Analysis
9.4 Bio-Rad laboratories, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 SWOT Analysis
9.5 Promega Corporation
- 9.5.1 Company Overview
- 9.5.2 Recent strategies and developments:
  - 9.5.2.1 Partnerships, Collaborations, and Agreements:
- 9.5.3 SWOT Analysis
9.6 New England Biolabs, Inc.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
9.7 Qiagen N.V.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Takara Bio Inc. (Takara Holdings Inc.)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expenses
9.10. Lonza Group Ltd. (Capsugel)
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Competent Cells Market, 2020 - 2023, USD Million
TABLE 2 North America Competent Cells Market, 2024 - 2031, USD Million
TABLE 3 North America Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 4 North America Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 5 North America Chemically Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Chemically Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Electrocompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Electrocompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Ultracompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Ultracompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 12 North America Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 13 North America Cloning Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Cloning Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Protein Expression Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Protein Expression Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Mutagenesis Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Mutagenesis Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 22 North America Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 23 North America Pharmaceutical & Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Pharmaceutical & Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Academic & Research Institutes Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Academic & Research Institutes Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 31 US Competent Cells Market, 2020 - 2023, USD Million
TABLE 32 US Competent Cells Market, 2024 - 2031, USD Million
TABLE 33 US Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 34 US Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 35 US Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 36 US Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 37 US Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 38 US Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 39 Canada Competent Cells Market, 2020 - 2023, USD Million
TABLE 40 Canada Competent Cells Market, 2024 - 2031, USD Million
TABLE 41 Canada Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 42 Canada Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 43 Canada Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 44 Canada Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 45 Canada Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 46 Canada Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 47 Mexico Competent Cells Market, 2020 - 2023, USD Million
TABLE 48 Mexico Competent Cells Market, 2024 - 2031, USD Million
TABLE 49 Mexico Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 50 Mexico Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 51 Mexico Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 52 Mexico Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 53 Mexico Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 54 Mexico Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 55 Rest of North America Competent Cells Market, 2020 - 2023, USD Million
TABLE 56 Rest of North America Competent Cells Market, 2024 - 2031, USD Million
TABLE 57 Rest of North America Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 58 Rest of North America Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 59 Rest of North America Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 60 Rest of North America Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 61 Rest of North America Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 62 Rest of North America Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 63 Key Information - Thermo Fisher Scientific, Inc.
TABLE 64 key Information - Merck KGaA
TABLE 65 key Information - Agilent Technologies, Inc.
TABLE 66 Key Information - Bio-Rad Laboratories, Inc.
TABLE 67 key Information - Promega Corporation
TABLE 68 Key Information - New England BioLabs, Inc.
TABLE 69 Key Information - Qiagen N.V.
TABLE 70 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 71 Key Information - Takara Bio Inc.
TABLE 72 Key Information -Lonza Group Ltd.

North America Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents